Independent committee report seeks Brexit healthcare clarity
March 21, 2018Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
NICE turns down Dompe’s eye drops for rare eye condition over price concerns
March 21, 2018Manufacturing and Production, Research and Development, Sales and Marketing Dompe, NICE, cenegermin, neurotrophic keratitis, pharma, rare disease
NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …
Takeda completes construction of new global headquarters in Tokyo
March 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo
Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital …
J&J’s longest-standing CFO finally steps down
March 21, 2018Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical
Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …
Celgene bucks trend to strengthen neuroscience pipeline
March 21, 2018Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical
Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …
Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3
March 20, 2018Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma
Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
Novartis steps into the medical marijuana business
March 20, 2018Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical
Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …
Regeneron’s Eylea smashes Phase 3 trial goal in diabetic retinopathy
March 20, 2018Manufacturing and Production, Research and Development Eylea, Regeneron, diabetes, pharma
Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a …
Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer
March 20, 2018Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
Vertex “astonished” by NHS England’s response to CF drug
March 20, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …
New Chief Science and Medical Officers for Gilead
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment
Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …
Male contraceptive pill hits safety goals
March 19, 2018Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical
A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …
Working Life: Chris Round, Head of EMEA Region, Merck KGaA
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma
Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …
“Game-changer” stem cell transplant shows strength in multiple sclerosis
March 19, 2018Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma
A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …
Lundbeck takes risk on Parkinson’s treatment, €905m on table
March 19, 2018Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical
CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …
India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust
March 19, 2018Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma
India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …
Pfizer to hang onto CEO, after 61% pay increase
March 19, 2018Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …
Top Ten most popular articles on Pharmafile.com this week
March 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten
Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
Rising levels of opioid prescriptions puts NHS under pressure
March 16, 2018Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical
It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …
NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy
March 16, 2018Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma
UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
